Navigation Links
Biopure Receives Notice of Nasdaq Delisting
Date:6/30/2009

CAMBRIDGE, Mass., June 30 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) announced that it has received notice from The Nasdaq Stock Market, by letter dated June 24, 2009, that it is out of compliance with the Nasdaq Marketplace Rules and its common stock may be delisted. The notice stated that the company no longer meets the minimum of $2,500,000 in stockholders' equity for continued listing on the Nasdaq Capital Market.

Nasdaq advised that the company has 15 calendar days to submit a plan to regain compliance. If such plan is accepted, Nasdaq may grant an extension of up to 105 days from the date of notification to regain compliance. If the Company is unable to regain compliance its common stock will be delisted. The company does not intend to submit a plan to regain compliance.

Biopure Corporation

Biopure Corporation develops and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues. The company has limited remaining cash. It is exploring the potential sale of some, substantially all, or all of its assets, and is evaluating liquidation.

    Contact:  Zaf Zafirelis
              Biopure Corporation
              (617) 234-6500
              IR@biopure.com


'/>"/>
SOURCE Biopure Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Biopure Announces Reverse Stock Split
2. Biopures Stock Symbol Reverts to BPUR
3. Biopure Announces Closing of $14.9 Million Financing
4. Four Abstracts by Biopure and Collaborating Scientists Accepted for Annual Meeting of American Society for Clinical Pharmacology and Therapeutics
5. Biopure Announces 2007 Fourth Quarter and Year-End Financial Results
6. Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
7. Biopure Reaffirms Strategy Following Recent NIH/FDA Workshop
8. Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance
9. Agency Takes Adverse Decision to Biopures Product Registration in South Africa
10. Biopure Sues National Institutes of Health Official
11. Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... September 23, 2014 Visiting Nurse Association ... home health care, hospice and palliative care, and community-based ... the Opening Bell last week at the New York ... Jersey philanthropist and social entrepreneur to care for immigrant ... Group has always worked to meet the urgent healthcare ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 Wellesley, Mass., ... reveals in its new report, Joint Reconstruction ... global market for joint reconstruction and replacement is expected ... a compound annual growth rate (CAGR) of 4.2% from ... among the major regions, surging at a CAGR of ...
(Date:9/23/2014)... September 23, 2014 AmerisourceBergen’s Innomar ... specialty market, is now providing U.S. manufacturers access ... 160,000-square-foot distribution center coupled with its fully-licensed wholesale ... industry has historically been difficult for smaller and ... regulation complexities. As a result of these regulations ...
(Date:9/23/2014)... 23, 2014 eCaring, a leading health ... into a contract to provide its unique Web-based home ... one of New York City’s largest not-for-profit health plans. ... eCaring system to help enhance the care of its ... 30 years, Elderplan has been at the forefront of ...
(Date:9/23/2014)... Becker's Hospital Review has published the 2014 ... Health Systems With Great Orthopedic Programs." , The ... have orthopedic surgery departments, programs or dedicated centers ... Exceptional orthopedic departments include physicians who provide outstanding ... professional athletes. , This is the fifth year ...
Breaking Medicine News(10 mins):Health News:NJ's Largest Nonprofit Home Health Care Agency Joins Deutsche Bank to Ring New York Stock Exchange Opening Bell 2Health News:Global Market for Joint Reconstruction and Replacement to reach $16.2 Billion in 2018; The U.S. Market Moving at 5.1% CAGR 2Health News:Global Market for Joint Reconstruction and Replacement to reach $16.2 Billion in 2018; The U.S. Market Moving at 5.1% CAGR 3Health News:AmerisourceBergen Paves Path to Canadian Markets 2Health News:AmerisourceBergen Paves Path to Canadian Markets 3Health News:eCaring Signs Care Management Contract with Elderplan, Inc. 2Health News:125 Hospitals With Great Orthopedic Programs 2Health News:125 Hospitals With Great Orthopedic Programs 3Health News:125 Hospitals With Great Orthopedic Programs 4Health News:125 Hospitals With Great Orthopedic Programs 5
... It has been proposed by Pharmac, to hold a meeting ... would allow the provision of drug to women with early ... patients with advanced breast cancer. Extension of the budget for ... has been planned. , ,The company officials are ...
... it is the socioeconomic status of an individual that ... new study published in the March 15, 2006 issue ... Society. ,The study found that education, community poverty, ... determining the outcomes as did age, disease stage, and ...
... by India's pharma major Ranbaxy Laboratories, Monday announced the launch ... give results in just a day. ,"A first of ... flu that can be effectively employed for mass screening and ... ten days, which other available tests take," said SRL Ranbaxy ...
... certain organizations that couples making a public display of their ... into// wedlock has been welcomed by some young lovers. ... on a Valentine's Day crackdown on lovers by the Akhil ... the Shiv Sena. ,The move is now being ...
... the Jharkhand government to donate nearly 100 acres of land ... The yoga guru has also been invited to set up ... using the abundant state reserve of medicinal plants. ... (MoU) with Ramdev next week when he arrives here for ...
... has urged that people restrict their telephonic conversations to a ... //cordless phones. ,Germany's federal bureau for radiation protection ... advised to put the base station in an area of ... time. The foyer or entrance is a good example. ...
Cached Medicine News:
(Date:9/23/2014)... 2014  MEDIMETRIKS PHARMACEUTICALS today announced that ... have been elected to Medimetriks, Board of Directors ... who will serve on Medimetriks, Audit Committee, brings ... the Company.  Mr. Lary is currently Managing Director, ... institutional investment firm.  Mr. Lary is responsible for ...
(Date:9/23/2014)... SAN FRANCISCO , Sept. 23, 2014  SiteOne ... round of equity financing. Led by Sears Capital Management ... and Joe Zakrzewski , the $1.5 million financing ... inhibitor program for pain and to further develop its ... other pain indications. In conjunction with the ...
(Date:9/23/2014)... , Sept 23, 2014  Vesselon, Inc. today announced ... of Directors, effective September 15, 2014. Dr. Raths, appointment ... its placement agent to market a private preferred Series ... early stroke treatment. "Jurgen,s deep experience across ... a great asset to Vesselon as we develop our ...
Breaking Medicine Technology:Medimetriks Pharmaceuticals, Inc. Welcomes Independent Directors Andrew Lary and William Resnick to its Board of Directors 2SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 2SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 3Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 2Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 3
... April 11, 2012   Prasco Laboratories ... version of Vancocin ® HCl Capsules (vancomycin hydrochloride ... in the U.S. under the Prasco label pursuant to ... VPHM).  Prasco intends to launch immediately. "We ...
... Healthcare announced today that nineteen (19) of their ... Use" requirements of their ONC-ATCB Certified NextGen™ Electronic ... collection last year and participated in the 2011 ... sponsored EHR Incentives program.  These Clients represent the ...
Cached Medicine Technology:Prasco Expands Authorized Generic Product Line with Vancocin® HCl Capsules 2Prasco Expands Authorized Generic Product Line with Vancocin® HCl Capsules 3TSI Healthcare Customers Receive Government Incentives for Meeting EHR Requirements 2
... specifically for posteror segment ... fluid from subretinal space. ... atraumatic entry through retinal ... holes. 6mm flexible tip ...
Product designed specifically for posteror segment surgical procedures. Facilitates posterior segment infusion. Flexible tubing 10in (25cm)....
For surgical treatment, repair and irrigation of the nasolacrimal system. Angled 45 degrees 13mm from end. Stainless steel probes, 20G x 1 3/4in (.90 x 45cm) Silicone rod, length 13 3/4in (40cm), Dia...
For surgical treatment, repair and irrigation of the nasolacrimal system. Stainless steel probes, 23G x4 1/2in (.60mm x 11cm) Silicone tubing, length 14in (35cm), ID: .012in (.30mm) OD: .025in (.60mm...
Medicine Products: